HilleVax, Inc. (HLVX) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for HilleVax, Inc. (HLVX).

Download PennyGems on Google Play Download PennyGems on the App Store

Equity Overview

Price & Market Data

Price: $2.06

Daily Change: $0.00 / 0.00%

Daily Range: $0 - $0

Market Cap: $103,258,528

Daily Volume: 0

Performance Metrics

1 Week: -2.37%

1 Month: -2.83%

3 Months: 11.35%

6 Months: 5.10%

1 Year: 28.75%

YTD: -0.48%

Company Details

Employees: 14

Sector: Health technology

Industry: Biotechnology

Country:

Details

HilleVax, Inc., a clinical-stage biopharmaceutical company, develops and commercializes vaccines in the United States. The company develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. It has a license agreement with Takeda Vaccines, Inc. to develop and commercialize HIL-214 pharmaceutical products. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.

Selected stocks

Lipocine Inc. (LPCN)

Braemar Hotels & Resorts Inc. (BHR)

Banco Bradesco Sa (BBDO)